153 related articles for article (PubMed ID: 7448820)
1. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
Tisman G; Wu SJ
Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
[TBL] [Abstract][Full Text] [Related]
2. Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.
Benz C; Tillis T; Tattelman E; Cadman E
Cancer Res; 1982 May; 42(5):2081-6. PubMed ID: 6175406
[TBL] [Abstract][Full Text] [Related]
3. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
4. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
[TBL] [Abstract][Full Text] [Related]
5. [A case of advance colon cancer responding to sequential methotrexate and 5-fluorouracil therapy].
Iida A; Komatsu T; Ookubo K; Ikeda N
Gan To Kagaku Ryoho; 1993 Apr; 20(5):661-3. PubMed ID: 8470927
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
8. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
[TBL] [Abstract][Full Text] [Related]
9. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
[TBL] [Abstract][Full Text] [Related]
10. Sequential methotrexate and 5-FU in breast cancer resistant to the conventional application of these drugs.
Herrmann R; Manegold C; Schroeder M; Tigges FJ; Bartsch H; Jungi F; Fritze D
Cancer Treat Rep; 1984 Oct; 68(10):1279-81. PubMed ID: 6525599
[TBL] [Abstract][Full Text] [Related]
11. [Methotrexate/5-fluorouracil therapy in gastric cancer with peritoneal metastasis].
Kosaka T; Sugaya J; Sejima T; Takano Y; Nakano Y; Akiyama T; Kiriyama M; Tomita F; Saito H; Kita I
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2266-9. PubMed ID: 7944456
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
13. Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results.
Pannuti F; Di Marco AR; Rossi AP; Rocchetta G; Rubino I; Giovannini M; Fruet F
Panminerva Med; 1981; 23(2):93-6. PubMed ID: 6459558
[No Abstract] [Full Text] [Related]
14. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
Klaassen U; Harstrick A; Wilke H; Seeber S
Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
[TBL] [Abstract][Full Text] [Related]
15. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
O'connor T; Rustum Y; Levine E; Creaven P
Cancer Chemother Pharmacol; 2008 Jan; 61(1):125-31. PubMed ID: 17426973
[TBL] [Abstract][Full Text] [Related]
17. [Sequential methotrexate and 5-fluorouracil].
Sasaki T
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy.
Fryar EB; Das JR; Davis JH; Desoto JA; Laniyan I; Southerland WM; Bowen D
Anticancer Res; 2006; 26(3A):1861-7. PubMed ID: 16827118
[TBL] [Abstract][Full Text] [Related]
19. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
